Uman Sense key facts
as of Oct 2026- Developer of a wearable stroke detection device designed to enable timely intervention for suspected stroke patients.
- Uman Sense is valued at approximately $46.3M as of Oct 2026 (last reported valuation).
- It has raised $9.2M; the latest was Later Stage VC ($6.3M) in Dec 2024.
- Notable investors include Almi Invest, Nordic Mentor Network For Entrepreneurship, EIT Health, Fårö Capital, GOBIA Enterprises — 15 tracked in total.
- Status: Privately Held (backing).
Uman Sense's last reported valuation, Dec 2024. Nothing priced has surfaced since.
- ·The complete investor list: 15 names
- ·Watch Uman Sense: the Monday email on marks, rounds and moves
Uman Sense funding rounds
No funding rounds for Uman Sense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Uman Sense
15+Uman Sense valuation
Uman Sense's last reported valuation was $46.3 million in Dec 2024. No priced round, secondary trade or fund mark has surfaced since.
Uman Sense investors
15 investors are on record for Uman Sense, including Almi Invest, Nordic Mentor Network For Entrepreneurship, EIT Health and Fårö Capital.
About Uman Sense
Developer of a wearable stroke detection device designed to enable timely intervention for suspected stroke patients. The company's platform continuously monitors users' arm movements, analyzes movement patterns to identify potential stroke symptoms, and automatically notifies pre-selected contacts when suspicion is detected, enabling healthcare providers and caregivers in the stroke care market to accelerate treatment decisions and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Lund, Sweden
- Founded
- 2014
- Employees
- 9
- Website
- umansense.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.